Additional evidence to support routine cytomegalovirus prophylaxis for all D+/R+ renal graft recipients

Transplantation. 2012 Mar 27;93(6):e21-2. doi: 10.1097/TP.0b013e318247a7d4.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Cytomegalovirus Infections / drug therapy*
  • Cytomegalovirus Infections / prevention & control*
  • Female
  • Ganciclovir / analogs & derivatives*
  • Humans
  • Kidney Transplantation*
  • Male
  • Transplantation*

Substances

  • Antiviral Agents
  • Ganciclovir